Valderm Aps' Other Investors

Valderm Aps raised a round of funding on , . Investors include SEED Capital.

Valderm ApS is focused on the development of the second generation anthracycline valrubicin for once daily topical treatment of hyperproliferative skin diseases e.g. psoriasis.…

Articles about Valderm Aps' Other Investors: